Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - PEPTIDE TECHNOLOGIES, INC.Financial_Report.xls
EX-31 - PEPTIDE TECHNOLOGIES, INC.ex31-2.txt
EX-32 - PEPTIDE TECHNOLOGIES, INC.ex32-2.txt
EX-32 - PEPTIDE TECHNOLOGIES, INC.ex32-1.txt
EX-31 - PEPTIDE TECHNOLOGIES, INC.ex31-1.txt

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 10-Q

(Mark One)

[X]                  QUARTERLY REPORT PURSUANT TO SECTION 13
                 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

                 For the quarterly period ended August 31, 2011

                                       OR

[ ]                 TRANSITION REPORT PURSUANT TO SECTION 13
                 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

           For the transition period from __________ to ______________

                        Commission File Number 333-133347

                              CREENERGY CORPORATION
                             -----------------------
             (Exact name of registrant as specified in its charter)


            Nevada                                       98-0479983
------------------------------                  ------------------------------
State or other jurisdiction of                        (I.R.S. Employer
incorporation or organization                        Identification No.)

    601 Union Street, Two Union Square, 42nd Floor, Seattle, Washington 98101
    -------------------------------------------------------------------------
               (Address of principal executive offices) (Zip Code)

       Registrant's telephone number, including area code: (780) 668-7422

Indicate by check mark whether the registrant (1) filed all reports  required to
be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of 1934 during
the past 12 months (or for such shorter  period that the registrant was required
to file such reports),  and (2) has been subject to such filing requirements for
the past 90 days.

Yes [X]     No [ ]

Indicate by check mark whether the registrant has submitted  electronically  and
posted on its corporate Web site, if any, every  Interactive  Data File required
to be submitted and posted pursuant to Rule 405 of Regulation S-T (ss.232.405 of
this chapter)  during the  preceding 12 months (or for such shorter  period that
the registrant was required to submit and post such files).     Yes     No

Indicate by check mark whether the registrant is a large  accelerated  filer, an
accelerated filer, a non-accelerated  filer, or a smaller reporting company. See
definition  of "large  accelerated  filer,"  "accelerated  filer"  and  "smaller
reporting company" in Rule 12b-2 of the Exchange Act.

Larger accelerated filer [ ]                       Accelerated filer [ ]
Non-accelerated filer [ ]                          Smaller reporting company [X]

Indicate by check mark whether registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act).  Yes [ ]      No [X]



                                       1


Number of shares issued and outstanding of the registrant's class of common stock as of September 30, 2011: 171,000,000 shares of common stock The Company recognized $nil revenues during the quarter ended August 31, 2011. 2
PART I - FINANCIAL INFORMATION Item 1. Financial Statements (Unaudited) Page ---- Interim Balance Sheets F-6 Interim Statements of Loss and Comprehensive Loss F-7 Interim Statements of Cash Flows F-8 Interim Statement of Changes in Stockholders' Equity F-9 Notes to Interim Financial Statements F-10 to F-15 Item 2. Management's Discussion and Analysis or Plan of Operations 16 Item 3 Quantitative and Qualitative Disclosure about Market Risk 18 Item 4 Controls and Procedures 18 PART II - OTHER INFORMATION Item 1 Legal Proceedings 19 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 19 Item 3. Defaults upon Senior Securities - Not Applicable 20 Item 4. Removed and Reserved 20 Item 5. Other Information 20 Item 6. Exhibits 20 SIGNATURES 21 3
PART I - FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS CREENERGY CORPORATION (A Development Stage Company) INTERIM FINANCIAL STATEMENTS (Expressed in U.S. Dollars) (Unaudited) AUGUST 31, 2011 Financial Statements Page Interim Balance Sheets F-6 Interim Statements of Loss and Comprehensive Loss F-7 Interim Statements of Cash Flows F-8 Interim Statement of Changes in Stockholders' Equity F-9 Notes to Interim Financial Statements F-10 to F-15 F-4
CREENERGY CORPORATION (A Development Stage Company) Interim Financial Statements (Expressed in U.S. Dollars) (Unaudited) August 31, 2011 F-5
CREENERGY CORPORATION (A Development Stage Company) INTERIM BALANCE SHEETS August 31, November 30, 2011 2010 (Unaudited) (Audited) ASSETS Current Assets Cash and cash equivalents $ 698 $ 6,090 Prepaid expenses 1,424 200 ----------------------------------------- Total Current Assets 2,122 6,290 Intangible Assets and Intellectual Property (Note 6) 375,000 - ----------------------------------------- TOTAL ASSETS $ 377,122 $ 6,290 ------------ ========================================= LIABILITIES AND STOCKHOLDERS' EQUITY LIABILITIES Current Liabilities Accounts payable and accrued liabilities (Note 3) $ 22,046 $ 13,133 Note payable (Note 4) 16,000 16,000 ----------------------------------------- Total Current Liabilities 38,046 29,133 ----------------------------------------- STOCKHOLDERS' EQUITY Capital Stock (Note 7) Authorized: 675,000,000 common shares, par value $0.001 per share Common shares issued and outstanding: 171,000,000 and 96,000,000 at August 31, 2011 and November 30, 2010 171,000 96,000 Additional paid-in capital 327,202 13,000 Accumulated other comprehensive income - 333 Accumulated deficit (105,837) (105,837) Accumulated deficit during Development Stage (53,289) (26,339) ----------------------------------------- Total Stockholders' Equity (Deficiency) 339,076 (22,843) ----------------------------------------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 377,122 $ 6,290 ------------------------------------------ ========================================= The accompanying notes are an integral part of these statements. F-6
CREENERGY CORPORATION (A Development Stage Company) INTERIM STATEMENTS OF LOSS AND COMPREHENSIVE LOSS (Unaudited) Cumulative Amounts from For the For the For the For the re-entering of three-month three-month nine-month nine-month development period ended period ended period ended period ended stage on June August 31, August 31, August 31, August 31, 26, 2010 to 2011 2010 2011 2010 August 31, 2011 ---------------------------------------------------------------------------------------------- Expenses Office and Administration $ 197 $ 1,231 $ 764 $ 1,356 $ 3,044 Professional fees 15,851 16,612 26,520 23,865 50,579 ---------------------------------------------------------------------------------------------- 16,048 17,843 27,284 25,221 53,623 ---------------------------------------------------------------------------------------------- Net Loss before Other Item (16,048) (17,843) (27,284) (25,221) (53,623) ---------------------------------------------------------------------------------------------- Other Item Foreign exchange gain - - 333 - 333 Net loss from Continuing Operations (16,048) (17,843) (26,951) (25,221) (53,290) ---------------------------------------------------------------------------------------------- Discontinued Operations (Note 9) Net Profit (loss) from discontinued operations - (40) - 3,871 - ---------------------------------------------------------------------------------------------- Net Loss For The Period (16,048) (17,883) (26,951) (21,350) (53,290) ============================================================================================== Other Comprehensive Loss Foreign currency translation adjustment - 6 (333) 7 (333) ---------------------------------------------------------------------------------------------- Comprehensive Loss For the Period $ (16,048) $ (17,877) $ (27,284) $ (21,343) $ (53,623) ============================================================================================== Loss per share from continuing operations - Basic and diluted $ (0.00) $ (0.00) $ (0.00) $ (0.00) Loss per share from discontinued operations - Basic and diluted $ (0.00) $ (0.00) $ (0.00) $ (0.00) ======================================================================== Weighted Average Number of Shares Outstanding 102,521,739 216,000,000 98,189,781 141,547,445 ======================================================================== The accompanying notes are an integral part of these statements. F-7
CREENERGY CORPORATION (A Development Stage Company) INTERIM STATEMENTS OF CASH FLOWS (Unaudited) Cumulative from re-entering of For the nine-month For the nine-month development stage period ended period ended on June 26, 2010 to August 31, 2011 August 31, 2010 August 31, 2011 Cash Flows used in Operating Net loss $ (26,951) $ (21,350) $ (53,290) Adjustments to Reconcile Net Loss to Net Cash Used by Operating Activities: Depreciation and amortization - 476 - Prepaid expenses (1,223) (1,000) 1,286 Accounts payable and accrued liabilities 8,913 7,511 21,297 --------------------------------------------------------------------------- Net Cash Used in Operating Activities (19,261) (14,363) (30,707) =========================================================================== Cash Flows from Investing Activities Purchase of intellectual property (375,000) - (375,000) --------------------------------------------------------------------------- Net Cash Used in Investing Activities (375,000) - (375,000) =========================================================================== Cash Flows From Financing Activities Issuance of common shares 375,000 - 375,000 Increase in note payable - 16,000 - Contribution by related party 14,202 - 27,202 --------------------------------------------------------------------------- Net Cash Provided by Financing Activities 389,202 16,000 402,202 =========================================================================== Decrease in Cash during the Period (5,059) 1,637 (3,505) Effect of Exchange Rate Changes on (333) 7 (333) Cash, Beginning of Period 6,090 2,841 4,536 --------------------------------------------------------------------------- Cash, End of Period $ 698 $ 4,485 $ 698 =========================================================================== Supplemental Disclosure of Cash Flow Cash paid for: Interest $ - $ - $ - Income taxes $ - $ - $ - The accompanying notes are an integral part of these statements. F-8
CREENERGY CORPORATION (A Development Stage Company) INTERIM STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY) For the Period from November 30, 2008 through August 31, 2011 (Unaudited) CAPITAL STOCK ACCUMULATED -------------------------------------------- ADDITIONAL DEFICIT DURING ACCUMULATED PAID-IN ACCUMULATED DEVELOPMENT COMPREHENSIVE SHARES AMOUNT CAPITAL DEFICIT STAGE INCOME (LOSS) TOTAL ----------------------------------------------------------------------------------------------------- CREENERGY CORPORATION (A Development Stage Company) NOTES TO INTERIM FINANCIAL STATEMENTS August 31, 2011 (Unaudited) 1. NATURE AND CONTINUANCE OF OPERATIONS a) Organization CREENERGY Corporation (formerly Online Originals, Inc.) (the "Company") was incorporated in the State of Nevada, United States of America, on November 18, 2005. On July 29, 2010, the Company's name was changed from Online Originals, Inc. to CREENERGY Corporation. The Company's yearend is November 30. b) Nature of Operations and Change in Business Since the date of inception on November 18, 2005, the Company's business plan was to develop a membership-based website art gallery/auction house specifically focused on displaying and selling original artwork. The Company changed its status from a development stage company to an operating company on November 30, 2009. Management realized that the results of operations from the sale of artwork lacks luster and decided to change the Company's business focus and plan for other strategic opportunities and discontinued the sale of artwork with effect from June 25, 2010. Accordingly, the Company has disclosed these activities as discontinued operations in the accompanying interim financial statements. Effective June 26, 2010, the Company became a development stage company focusing on new business development in the form of obtaining leases for the exploration and production of oil and gas in areas of northern Alberta, Canada. On August 23, 2011, the Company entered into an asset purchase with William Campbell and Scott McKinley to acquire intangible assets and intellectual property known as the Peptide Technology Platform. c) Unaudited Statements While the information presented in the accompanying interim financial statements is unaudited, it includes all adjustments which are, in the opinion of management, necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented. Except as disclosed below, these interim financial statements follow the same accounting policies and methods of their application as the Company's audited November 30, 2010 annual financial statements. It is suggested that these interim financial statements be read in conjunction with the Company's audited financial statements for the year ended November 30, 2010, included in the annual report previously filed with the Securities and Exchange Commission on Form 10-K. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the full year. The information as of November 30, 2010 is taken from the audited financial statements as of that date. d) Basis of Presentation The accompanying interim financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which contemplates the continuation of the Company as a going concern. However, the Company has negative working capital at August 31, 2011 and has losses to date of approximately $159,000. These matters raise substantial doubt about its ability to continue as a going concern. In view of these matters, realization of certain of the assets in the accompanying balance sheet is dependent upon its ability to meet its financing requirements, raise additional capital, and the success of its future operations. There is no assurance that future capital raising plans will be successful in obtaining sufficient funds to assure its eventual profitability. Management is actively seeking to add new products and/or services in order to show profitability. In addition, one of the members of the board of directors has agreed to loan funds to the Company if needed. F-10
CREENERGY CORPORATION (A Development Stage Company) NOTES TO INTERIM FINANCIAL STATEMENTS ------------------------------------- August 31, 2011 (Unaudited) We believe that actions planned and presently being taken to revise its operating and financial requirements will provide the opportunity for the Company to continue as a going concern. The interim financial statements do not include any adjustments that might result from these uncertainties. 2. RECENT ACCOUNTING PRONOUNCEMENTS In September 2011, the Financial Accounting Standards Boars ("FASB") issued Accounting Standards Update ("ASU") 2011-08, "Intangibles - Goodwill and Other" which allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. Under these amendments, an entity would not be required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. ASU 2011-08 will be effective for the Company in fiscal 2013, with early adoption permitted. The Company does not expect the adoption of this update will have a material effect on its financial statements. In June 2011, the FASB issued ASU 2011-05, "Presentation of Comprehensive Income". This update presents an entity with the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In both choices, an entity is required to present each component of net income along with total net income, each component of other comprehensive income along with a total for other comprehensive income, and a total amount for comprehensive income. This update eliminates the option to present the components of other comprehensive income as part of the statement of changes in stockholders' equity. The amendments in this update do not change the items that must be reported in other comprehensive income or when an item of other comprehensive income must be reclassified to net income. As ASU 2011-05 relates only to the presentation of Comprehensive Income, the Company does not expect that the adoption of this update will have a material effect on its financial statements. In May 2011, the FASB issued ASU No. 2011-04, "Fair Value Measurement" to amend the accounting and disclosure requirements on fair value measurements. This ASU limits the highest-and-best-use measure to nonfinancial assets, permits certain financial assets and liabilities with offsetting positions in market or counterparty credit risks to be measured at a net basis, and provides guidance on the applicability of premiums and discounts. Additionally, this update expands the disclosure on Level 3 inputs by requiring quantitative disclosure of the unobservable inputs and assumptions, as well as description of the valuation processes and the sensitivity of the fair value to changes in unobservable inputs. ASU No. 2011-04 is to be applied prospectively and is effective during interim and annual periods beginning after 15 December 2011. The Company does not expect the adoption of this update will have a material effect on its financial statements. In January 2010, the FASB issued ASU 2010-06, "Improving Disclosures about Fair Value Measurements". This update requires additional disclosure within the roll forward of activity for assets and liabilities measured at fair value on a recurring basis, including transfers of assets and liabilities between Level 1 and Level 2 of the fair value hierarchy and the separate presentation of purchases, sales, issuances and settlements of assets and liabilities within Level 3 of the fair value hierarchy. In addition, the update requires enhanced disclosures of the valuation techniques and inputs used in the fair value measurements within Levels 2 and 3. The new disclosure requirements are effective for interim and annual periods beginning after 15 December 2009, except for the disclosure of purchases, sales, issuances and settlements of Level 3 measurements. Those disclosures are effective for fiscal years beginning after 15 December 2010. As ASU 2010-06 only requires enhanced disclosures, the Company does not expect that the adoption of this update will have a material effect on its financial statements. F-11
CREENERGY CORPORATION (A Development Stage Company) NOTES TO INTERIM FINANCIAL STATEMENTS ------------------------------------- August 31, 2011 (Unaudited) 3. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payable and accrued liabilities are non-interest bearing, unsecured and have settlement dates within one year. 4. NOTE PAYABLE As of August 31, 2011, the Company had $16,000 note payable to an unrelated party for expenses paid on behalf of the Company. The note payable is unsecured, non-interest bearing, and has no fixed terms of repayment. 5. RELATED PARTY TRANSACTIONS During the nine month period ended August 31, 2011, a director and shareholder of the Company made cash contribution in the amount of $14,202 (August 31, 2010 - $Nil, Cumulative - $27,202). 6. INTANGIBLE ASSETS AND INTELLECTUAL PROPERTY On August 23, 2011, the Company entered into an asset purchase with William Campbell and Scott McKinley to acquire intangible assets and intellectual property known as the Peptide Technology Platforms (the "Platforms") in exchange for 75,000,000 common shares of the Company (issued on August 23, 2011) (Note 7). The Platforms includes but are not limited to the following: o Proteomic research platforms which include proprietary solid phase media side-chain protected peptide array synthesis; o Peptide libraries; o Combination design techniques; o Peptide molecule modifications; o A proprietary genetic algorithm that designs peptides for goodness to fit to a target; and o Proprietary and patented application platforms, including a viral vector gene therapy and epitode-mapping based vaccine development. 7. CAPITAL STOCK Authorized The Company's authorized common stock consists of 675,000,000 shares of common stock with a par value of $0.001 per share. On August 10, 2010, the Company increased the number of authorized share capital from 75,000,000 shares of common stock to 675,000,000 shares of common stock with the same par value of $0.001 per share. Issued and outstanding On June 2, 2010, and effective August 10, 2010, the directors of the Company approved a forward split of the common stock of the Company on a basis of 30 new common shares for 1 old common share. As a result of the forward stock split, 208,800,000 additional shares were issued. Capital and additional paid-in capital have been adjusted accordingly. When adjusted retroactively, there was an $119,501 shortage of additional paid-in capital; thus an adjustment to accumulated deficit of $104,000 was recorded on May 21, 2010 (the date of issuance of 120,000,000 shares) and $15,501 to the beginning balance. The interim financial statements contained herein reflect the appropriate values for capital stock and accumulated deficit. Unless otherwise noted, all references in the accompanying interim financial statements to the number of common shares and per share amounts have been retroactively restated to reflect the forward stock split. F-12
CREENERGY CORPORATION (A Development Stage Company) NOTES TO INTERIM FINANCIAL STATEMENTS ------------------------------------- August 31, 2011 (Unaudited) The total issued and outstanding capital stock is 171,000,000 common shares with a par value of $0.001 per common share. The Company's common stock issuances to date are as follows: i) On November 18, 2005, 54,000,000 shares of the Company's common stock were issued to a former director and officer of the Company for cash proceeds of $18,000. ii) On November 28, 2005, 21,000,000 shares of the Company's common stock were issued to a former director and officer of the company for cash proceeds of $7,000. iii) On July 21, 2006, the Company completed a public offering and issued 21,000,000 shares of the Company's common stock for cash totalling $70,000. The Company incurred offering costs of $14,501 related to this offering, resulting in net proceeds of $55,499. iv) On May 21, 2010, 120,000,000 shares of the Company's restricted common stock, valued at $16,000, were issued to a former director and officer of the Company. On October 29, 2010, the 120,000,000 restricted common shares of the Company previously issued to a former director and officer of the Company were returned to treasury for no consideration. The shares were cancelled on 2 November 2010. v) On August 23, 2011, the Company issued 75,000,000 shares of its restricted common stock in exchange for intangible assets and intellectual property (Note 6). 8. INCOME TAXES The Company has losses carry forward for income tax purposes to August 31, 2011. There are no current or deferred tax expenses for the period ended August 31, 2011 due to the Company's loss position. The Company has fully reserved for any benefits of these losses. The deferred tax consequences of temporary differences in reporting items for financial statement and income tax purposes are recognized, as appropriate. Realization of the future tax benefits related to the deferred tax assets is dependent on many factors, including the Company's ability to generate taxable income within the net operating loss carryforward period. Management has considered these factors in reaching its conclusion as to the valuation allowance for financial reporting purposes. The provision for refundable federal income tax consists of the following: For the nine-month period ended ------------------------------------------- August 31, 2011 August 31, 2010 ------------------------------------------- Deferred tax asset attributable to Current operations $ 9,550 $ 7,473 Less: Change in valuation allowance (9,550) (7,473) ------------------------------------------- Net refundable amount $ - $ - ------------------------------------------- The composition of the Company's deferred tax asset as at August 31, 2011 and November 30, 2010 are as follows: August 31, 2011 November 30, 2010 (Unaudited) (Audited) ------------------------------------------- Net operation loss carry-forward $ 143,959 116,675 Statutory federal income tax rate 35% 35% Deferred tax assets 50,386 40,836 Less: Valuation allowance (50,386) (40,836) ------------------------------------------ Net Deferred Tax Assets $ - $ - ------------------------------------------ F-13
CREENERGY CORPORATION (A Development Stage Company) NOTES TO INTERIM FINANCIAL STATEMENTS ------------------------------------- August 31, 2011 (Unaudited) The potential income tax benefit of these losses has been offset by a full valuation allowance. As at August 31, 2011, the Company has an unused net operating loss carry forward balance of approximately $143,959 that is available to offset future taxable income. This unused net operation loss carry forward balance for income tax purposes expires as follows: $ 2025 2,680 2026 14,178 2027 37,588 2028 28,450 2029 6,389 2030 27,390 2031 27,284 -------------------- 143,959 -------------------- 9. DISCONTINUED OPERATIONS AND NEW DEVELOPMENTS The Company's attempts over the past years to build a business that provides a website where members and customers are able to bid on and purchase pieces of art had not come to fruition so management decided to change the business focus and look for other opportunities. Therefore, management decided to discontinue selling art pieces and reflect such discontinuance in its operating statement and cash flow statements effective June 25, 2010. Management decided on that date to focus on new business development in the form of obtaining leases for the exploration and production of oil and gas in First Nation areas of northern Alberta, Canada. In August 2011 the Company acquired intangible assets and intellectual property known as Peptide Technology Platform. During the nine month period ended August 31, 2011 and the nine month period ended August 31, 2010, the Company had $Nil and $6,042 respectively, related to its discontinued operations. For the nine month For the nine month period ended period ended August 31, 2011 August 31, 2010 Revenue $ - $ 6,042 ------------------------------------------------- Expenses Depreciation and amortization - 477 Office and administration - 1,694 ------------------------------------------------- - 2,171 ------------------------------------------------- Net Profit from Discontinued Operations $ - $ 3,871 ================================================= 10. CONTINGENCY On November 22, 2010, the Company was served with a claim filed by a former director and officer of the Company. The claim alleges that the former director and officer of the Company suffered losses and damages as a result of the failure of the Company in providing him with corporate documents and implementing a change of the board of directors. The Company has retained legal counsel to address the claim. On December 8, 2010, the Company filed F-14
CREENERGY CORPORATION (A Development Stage Company) NOTES TO INTERIM FINANCIAL STATEMENTS ------------------------------------- August 31, 2011 (Unaudited) a Statement of Defense requesting that the claim be dismissed. In the opinion of management, this claim is without merit and the Company intends to defend this claim vigorously. As a loss is not deemed probable, and as such, no accruals have been made as of August 31, 2011. 11. COMPARATIVE FIGURES Certain comparative figures have been adjusted to conform to the current period's presentation. 12. SUBSEQUENT EVENTS There following events occurred during the period from the nine month period ended August 31, 2011 to the date the interim financial statements are available to be issued on October 11, 2011: Professional Services Agreement On October 3, 2011, the Company formalized an agreement with a consulting firm for services related to debt and equity capital raising and business development activities. Under this agreement, consulting fees payable will accrue at the rate of $40,000 per month for a term of three years, effective October 1, 2011. Additionally, commissions will be paid on debt or equity funding (i.e., private offerings) generated by the consulting firm, at a rate of ten percent (10%). At the time of the completion of the offering, the costs are charged against the capital raised. Change of Directors and Officers On October 3, 2011 William Campbell and Scott McKinley were appointed to the Board of Directors. Effective October 3, 2011, Shari Sookarookoff resigned as President, Secretary, Treasurer, Chief Executive Officer and Chief Financial Officer of the Company. Dr. William Campbell, Ph.D. was appointed Chief Scientific Officer, Dr. Scott McKinley, Ph.D. was appointed Chairman and Chief Operating Officer, Deborah Fortescue-Merrin, B.Sc. was appointed as President and Richard Fortescue, was appointed Chief Financial Officer. Ms. Fortescue-Merrin and Mr. Fortescue are siblings. On September 9, 2011 the Company adopted a proposal to change the Company's name from Creenergy Corporation to Peptide Technologies, Inc to be effective on or about October 13, 2011. F-15
Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS The following discussion should be read in conjunction with our unaudited financial statements and notes thereto included herein. In connection with, and because we desire to take advantage of, the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, we caution readers regarding certain forward looking statements in the following discussion and elsewhere in this report and in any other statement made by, or on our behalf, whether or not in future filings with the Securities and Exchange Commission. Forward-looking statements are statements not based on historical information and which relate to future operations, strategies, financial results, or other developments. Forward-looking statements are necessarily based upon estimates and assumptions that are inherently subject to significant business, economic, and competitive, uncertainties and contingencies, many of which are beyond our control and many of which, with respect to future business decisions, are subject to change. These uncertainties and contingencies can affect actual results and could cause actual results to differ materially from those expressed in any forward-looking statements made by or on our behalf. We disclaim any obligation to update forward-looking statements. The following discussion of the plan of operation, financial condition, results of operations, cash flows and changes in financial position of our Company should be read in conjunction with our most recent financial statements and notes appearing elsewhere in this Quarterly Report on Form 10-Q, our Quarterly Report on Form 10-Q filed on July 14, 2011, our Quarterly Report on Form 10-Q filed on April 14, 2011, and our Annual Report on Form 10-K filed on March 11, 2011. The independent registered public accounting firms' reports on the Company's financial statements as of November 30, 2010, and for each of the years in the two-year period then ended; include a "going concern" explanatory paragraph that describes substantial doubt about the Company's ability to continue as a going concern. Management's plans in regard to the factors prompting the explanatory paragraph are discussed below and also in Note 1 to the unaudited quarterly financial statements. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. Discontinued Operations and New Developments Since inception, the Company's business plan was to develop a membership based website art gallery/auction house specifically focused on displaying and selling original artwork. The Company changed its status from a development stage company to an operating company on November 30, 2009. Management realized that the results of operations from the sale of artwork was lack-luster, and it was decided to change the Company's business focus and plan for other strategic opportunities and discontinued the sale of artwork to be effective June 25, 2010. Effective June 26, 2010, the Company started to focus on a new business development. On July 29, 2010, the Company's name changed from Online Originals, Inc. to Creenergy Corporation. The name change was intended to convey a sense of the Company's new business focus as it looked to pursue other opportunities. Specifically, the Company intended to obtain leases for the exploration and production of oil and gas in northern Canada and the United States. These objectives have not been realized and the Company has abandoned its efforts in this area. On August 23, 2011, the Company entered into an Asset Purchase Agreement in which the Company, in exchange for 75,000,000 shares of the Company's restricted common stock, will receive all rights and title to proprietary technologies and formulas involving the application of specialty peptides. Having done this, the Company has changed its business focus from obtaining leases for the exploration and production of oil and gas in areas of northern Alberta, Canada, to the manufacturing and distribution of natural peptide solutions to combat the economic burden caused by the zebra and quagga mussels to the hydropower electricity industry. Principal Products and Services ------------------------------- The Company intends to develop and provide a sustainable natural solution that addresses the economic burdens caused by the zebra and quagga mussels, without harming other organisms or depleting a segment of the natural food chain. 16
Change of Directors and Officers As a result of the changes in our business plan and operations, the following changes in management occurred: - On October 3, 2011 Drs. William Campbell and Scott McKinley were appointed to the Board of Directors. - Effective October 3, 2011, Shari Sookarookoff resigned as President, Secretary, Treasurer, Chief Executive Officer and Chief Financial Officer of the Company. - Dr. William Campbell, Ph.D. was appointed Chief Scientific Officer. - Dr. Scott McKinley, Ph.D. was appointed Chairman and Chief Operating Officer. - Deborah Fortescue-Merrin was appointed as President. - Richard Fortescue was appointed Chief Financial Officer. Ms. Fortescue-Merrin and Mr. Fortescue are siblings. On September 9, 2011 the Company adopted a proposal to change the Company's name from Creenergy Corporation to Peptide Technologies, Inc to be effective on or about October 13, 2011. Material Changes in Financial Condition At August 31, 2011, our cash balance was $698. In addition, we have prepaid expenses of $1,424. Cash on hand is currently our only source of liquidity. We do not have any lending arrangements in place with banking or financial institutions and we do not anticipate that we will be able to secure these funding arrangements in the near future. At August 31, 2011, we had a working capital deficit of $35,924 compared to a working capital deficit of $22,843 at November 30, 2010. At August 31, 2011, our total assets consisted of cash of $698, prepaid expenses of $1,424, and Intangible Asset and Intellectual Property of $375,000. This compares with total assets at November 30, 2010, which consisted of cash of $6,090, and prepaid expenses of $200. At August 31, 2011, our total current liabilities increased to $38,046 from $29,133 at November 30, 2010. During the three months ended August 31, 2011, accounts payable and accrued liabilities increased by $15,371. We believe our existing cash balances will not be sufficient to carry our normal operations over the next three (3) months. Our short and long-term survival is dependent on sales of securities as necessary or from shareholder loans, and thus, to the extent that we require additional funds to support our operations or the expansion of our business, we will attempt to sell additional equity shares or issue debt. Any sale of additional equity securities will result in dilution to our stockholders. Continuing events in worldwide capital markets may make it more difficult for us to raise additional equity or capital. There can be no assurance that additional financing, if required, will be available to us or on acceptable terms. Result of Operations For The Three Months Ended August 31, 2011 Compared To The Three Months Ended August 31, 2010. We recognized nil revenues from operational sales during the three months ending August 31, 2011. During the three months ended August 31, 2011, operating expenses were $16,048 compared to $17,843 for the three months ended August 31, 2010. The decrease of $1,795 was due to decrease in our operational activities over the prior period. Operating expenses during the three months ended August 31, 2011, consisted of professional fees of $15,851 and office and administration costs of $197 compared to professional fees of $16,612 and office and administration fees of $1,231 incurred for the three months ended August 31, 2010. We do not expect such decreases to continue as we begin to pursue business opportunities related to the peptide technologies. We recognized a net loss of $16,048 for the three months ended August 31, 2011, compared to a net loss of $17,883 for the three months ended August 31, 2010. F-17
For the Nine Months Ended August 31, 2011 Compared to the Nine Months Ended August 31, 2010. We recognized nil revenues from operational sales during the nine months ending August 31, 2011. We do not show any cumulative revenue amounts since re-entering the development stage on June 26, 2010. During the nine months ended August 31, 2011, operating expenses were $26,951 compared to $25,221 for the nine months ended August 31, 2010. The increase of $1,730 was due to increase in our operational activities over the prior period. Operating expenses during the nine months ended August 31, 2011, consisted of professional fees of $26,520 and office and administration costs of $764 compared to professional fees of $23,865 and office and administration fees of $1,356 incurred for the nine months ended August 31, 2010. We do expect such increases to continue as we begin to pursue business opportunities related to the peptide technologies. We recognized a net loss of $26,951 for the nine months ended August 31, 2011, compared to a net loss of $21,350 for the nine months ended August 31, 2010. The cumulative net loss of $53,290 is for the period June 26, 2010, to August 31, 2011. Off-Balance Sheet Arrangements We currently do not have any off-balance sheet arrangements. Critical Accounting Policies and Estimates The preparation of the Company's financial statements in conformity with generally accepted accounting principles in the United States requires management to make assumptions and estimates that affect the reported amounts of assets, liabilities, revenues and expenses as well as the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The following is a summary of the significant accounting policies and related estimates that affect the Company's financial disclosures. Revenue Recognition Revenues are recognized when persuasive evidence of an arrangement exists, delivery has occurred (or service has been performed), the sales price is fixed and determinable and collectability is reasonably assured. Revenue recognition from consignment inventory consists of commission income. Foreign Currency Translations The functional currency is the Canadian dollar and the reporting currency is the U.S. dollar. At each balance sheet date, assets and liabilities that are denominated in a currency other than U.S. dollars are adjusted to reflect the current exchange rate which may give rise to a foreign currency translation adjustment accounted for as a separate component of shareholders' equity and included in other comprehensive loss. Revenues and expenses are translated at the average daily rate for the year covering the financial statement year to approximate the rate of exchange on the transaction date. Exchange gains and losses are included in the determination of net income (loss) for the period. ITEM 3. QUANTATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. As a "smaller reporting company" as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item. 18
ITEM 4. CONTROLS AND PROCEDURES As of the end of the period covered by this report, we conducted an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the 1934 Act). Based on this evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that we file or submit under the 1934 Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms. Our management is responsible for establishing and maintaining adequate internal control over financial reporting for the company in accordance with as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Management's assessment of the effectiveness of the small business issuer's internal control over financial reporting is as of the quarter ended August 31, 2011. We believe that our internal control over financial reporting was not effective due to material weaknesses in the system of internal control. Specifically, management identified the following control deficiency: The Company has installed accounting software that does not prevent erroneous or unauthorized changes to previous reporting periods and does not provide an adequate audit trail of entries made in the accounting software. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended August 31, 2011, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. PART II - OTHER INFORMATION Item 1. Legal Proceedings On November 22, 2010, the Company was served with a claim filed by a former director and officer of the Company. The claim, filed in the court of Queen's Bench of Alberta, Canada, alleges that the former director and officer of the Company suffered losses and damages as a result of the failure of the Company in providing him with corporate documents and implementing a change of the board of directors. The Company has retained legal counsel to address the claim. On December 8, 2010, the Company filed a Statement of Defense requesting that the claim be dismissed. The Company intends to defend this claim vigorously. Other then the above preceding, the Company is not a party to any other pending legal proceedings, nor is the Company aware of any civil proceeding or government authority contemplating any legal proceeding as of the date of this filing. Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS None. 19
Item 3. DEFAULTS UPON SENIOR SECURITIES None. Item 4. REMOVED AND RESERVED. Item 5. Other Information None Item 6. Exhibits (a) Pursuant to Item 601 of Regulation S-K, the following exhibits are included herein. Exhibit Number Description 31.1 Section 302 Certification - President 31.2 Section 302 Certification - Chief Financial Officer. 32.1 Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 - President. 32.2 Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 - Chief Financial Officer. 20
SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on this 11th day of October, 2011. CREENERGY CORPORATION Date: October 11, 2011 By: /s/ Deborah Fortescue-Merrin ---------------------------- Name: Deborah Fortescue-Merrin Title: President Date: October 11, 2011 By: /s/ Richard Fortescue --------------------- Name: Richard Fortescue Title: Chief Financial Officer 2